nodes	percent_of_prediction	percent_of_DWPC	metapath
Levorphanol—OPRM1—nicotine dependence	0.94	1	CbGaD
Levorphanol—Suicide attempt—Varenicline—nicotine dependence	0.00487	0.106	CcSEcCtD
Levorphanol—Thinking abnormal—Varenicline—nicotine dependence	0.00302	0.066	CcSEcCtD
Levorphanol—Abnormal dreams—Varenicline—nicotine dependence	0.00273	0.0597	CcSEcCtD
Levorphanol—Mental disability—Varenicline—nicotine dependence	0.0024	0.0524	CcSEcCtD
Levorphanol—Amnesia—Varenicline—nicotine dependence	0.00213	0.0467	CcSEcCtD
Levorphanol—Lethargy—Varenicline—nicotine dependence	0.00205	0.0447	CcSEcCtD
Levorphanol—Affect lability—Varenicline—nicotine dependence	0.00197	0.0431	CcSEcCtD
Levorphanol—Urinary retention—Varenicline—nicotine dependence	0.00191	0.0417	CcSEcCtD
Levorphanol—Mood swings—Varenicline—nicotine dependence	0.0019	0.0415	CcSEcCtD
Levorphanol—Levallorphan—OPRM1—nicotine dependence	0.00168	0.16	CrCbGaD
Levorphanol—Bradycardia—Varenicline—nicotine dependence	0.00141	0.0309	CcSEcCtD
Levorphanol—Visual impairment—Varenicline—nicotine dependence	0.00134	0.0292	CcSEcCtD
Levorphanol—Arrhythmia—Varenicline—nicotine dependence	0.00124	0.0271	CcSEcCtD
Levorphanol—Muscle spasms—Varenicline—nicotine dependence	0.00116	0.0254	CcSEcCtD
Levorphanol—Dezocine—OPRM1—nicotine dependence	0.00114	0.108	CrCbGaD
Levorphanol—Agitation—Varenicline—nicotine dependence	0.00111	0.0243	CcSEcCtD
Levorphanol—Palpitations—Varenicline—nicotine dependence	0.00107	0.0233	CcSEcCtD
Levorphanol—Convulsion—Varenicline—nicotine dependence	0.00105	0.0229	CcSEcCtD
Levorphanol—Pentazocine—OPRM1—nicotine dependence	0.00104	0.0991	CrCbGaD
Levorphanol—Dry mouth—Varenicline—nicotine dependence	0.001	0.022	CcSEcCtD
Levorphanol—Shock—Varenicline—nicotine dependence	0.000969	0.0212	CcSEcCtD
Levorphanol—Butorphanol—OPRM1—nicotine dependence	0.000967	0.0922	CrCbGaD
Levorphanol—Tachycardia—Varenicline—nicotine dependence	0.000961	0.021	CcSEcCtD
Levorphanol—Hyperhidrosis—Varenicline—nicotine dependence	0.000952	0.0208	CcSEcCtD
Levorphanol—Dextromethorphan—CHRNB4—nicotine dependence	0.000946	0.0902	CrCbGaD
Levorphanol—Hypotension—Varenicline—nicotine dependence	0.00092	0.0201	CcSEcCtD
Levorphanol—Insomnia—Varenicline—nicotine dependence	0.000891	0.0195	CcSEcCtD
Levorphanol—Dyspepsia—Varenicline—nicotine dependence	0.000867	0.019	CcSEcCtD
Levorphanol—Dextromethorphan—CHRNB2—nicotine dependence	0.000865	0.0825	CrCbGaD
Levorphanol—Constipation—Varenicline—nicotine dependence	0.000842	0.0184	CcSEcCtD
Levorphanol—Dihydrocodeine—OPRM1—nicotine dependence	0.000822	0.0784	CrCbGaD
Levorphanol—Feeling abnormal—Varenicline—nicotine dependence	0.000812	0.0178	CcSEcCtD
Levorphanol—Gastrointestinal pain—Varenicline—nicotine dependence	0.000805	0.0176	CcSEcCtD
Levorphanol—Urticaria—Varenicline—nicotine dependence	0.000783	0.0171	CcSEcCtD
Levorphanol—Abdominal pain—Varenicline—nicotine dependence	0.000779	0.017	CcSEcCtD
Levorphanol—Pruritus—Varenicline—nicotine dependence	0.000697	0.0152	CcSEcCtD
Levorphanol—Dextromethorphan—CHRNA3—nicotine dependence	0.000656	0.0625	CrCbGaD
Levorphanol—Dizziness—Varenicline—nicotine dependence	0.000651	0.0142	CcSEcCtD
Levorphanol—Hydrocodone—OPRM1—nicotine dependence	0.00063	0.0601	CrCbGaD
Levorphanol—Vomiting—Varenicline—nicotine dependence	0.000626	0.0137	CcSEcCtD
Levorphanol—Rash—Varenicline—nicotine dependence	0.000621	0.0136	CcSEcCtD
Levorphanol—Dermatitis—Varenicline—nicotine dependence	0.000621	0.0136	CcSEcCtD
Levorphanol—Nausea—Varenicline—nicotine dependence	0.000585	0.0128	CcSEcCtD
Levorphanol—Hydromorphone—OPRM1—nicotine dependence	0.000522	0.0498	CrCbGaD
Levorphanol—Morphine—OPRM1—nicotine dependence	0.000444	0.0423	CrCbGaD
Levorphanol—Dextromethorphan—CHRNA4—nicotine dependence	0.000405	0.0386	CrCbGaD
Levorphanol—Dextromethorphan—OPRM1—nicotine dependence	0.000373	0.0355	CrCbGaD
Levorphanol—OPRD1—Peptide GPCRs—OPRM1—nicotine dependence	0.000236	0.0576	CbGpPWpGaD
Levorphanol—OPRD1—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.000223	0.0542	CbGpPWpGaD
Levorphanol—OPRK1—Peptide GPCRs—OPRM1—nicotine dependence	0.000207	0.0505	CbGpPWpGaD
Levorphanol—OPRK1—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.000195	0.0475	CbGpPWpGaD
Levorphanol—OPRM1—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.000165	0.0402	CbGpPWpGaD
Levorphanol—OPRD1—GPCR ligand binding—TAS2R16—nicotine dependence	0.000135	0.0328	CbGpPWpGaD
Levorphanol—OPRK1—GPCR ligand binding—TAS2R16—nicotine dependence	0.000118	0.0288	CbGpPWpGaD
Levorphanol—OPRD1—Peptide ligand-binding receptors—OPRM1—nicotine dependence	0.000111	0.0271	CbGpPWpGaD
Levorphanol—OPRM1—GPCR ligand binding—TAS2R16—nicotine dependence	9.99e-05	0.0243	CbGpPWpGaD
Levorphanol—OPRK1—Peptide ligand-binding receptors—OPRM1—nicotine dependence	9.75e-05	0.0237	CbGpPWpGaD
Levorphanol—OPRD1—G alpha (i) signalling events—OPRM1—nicotine dependence	9.38e-05	0.0228	CbGpPWpGaD
Levorphanol—OPRD1—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	8.71e-05	0.0212	CbGpPWpGaD
Levorphanol—OPRK1—G alpha (i) signalling events—OPRM1—nicotine dependence	8.23e-05	0.02	CbGpPWpGaD
Levorphanol—OPRK1—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	7.64e-05	0.0186	CbGpPWpGaD
Levorphanol—OPRD1—GPCR downstream signaling—TAS2R16—nicotine dependence	7.62e-05	0.0185	CbGpPWpGaD
Levorphanol—OPRD1—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	7.46e-05	0.0182	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—TAS2R16—nicotine dependence	6.92e-05	0.0168	CbGpPWpGaD
Levorphanol—OPRD1—G alpha (i) signalling events—DRD2—nicotine dependence	6.78e-05	0.0165	CbGpPWpGaD
Levorphanol—OPRK1—GPCR downstream signaling—TAS2R16—nicotine dependence	6.68e-05	0.0163	CbGpPWpGaD
Levorphanol—OPRK1—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	6.54e-05	0.0159	CbGpPWpGaD
Levorphanol—OPRD1—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	6.3e-05	0.0153	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—TAS2R16—nicotine dependence	6.06e-05	0.0148	CbGpPWpGaD
Levorphanol—OPRD1—GPCR downstream signaling—FGD1—nicotine dependence	5.98e-05	0.0145	CbGpPWpGaD
Levorphanol—OPRK1—G alpha (i) signalling events—DRD2—nicotine dependence	5.95e-05	0.0145	CbGpPWpGaD
Levorphanol—OPRD1—GPCR ligand binding—OPRM1—nicotine dependence	5.68e-05	0.0138	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—TAS2R16—nicotine dependence	5.64e-05	0.0137	CbGpPWpGaD
Levorphanol—OPRK1—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	5.52e-05	0.0134	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—FGD1—nicotine dependence	5.43e-05	0.0132	CbGpPWpGaD
Levorphanol—OPRD1—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	5.39e-05	0.0131	CbGpPWpGaD
Levorphanol—OPRK1—GPCR downstream signaling—FGD1—nicotine dependence	5.24e-05	0.0128	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—TAS2R16—nicotine dependence	5.13e-05	0.0125	CbGpPWpGaD
Levorphanol—OPRM1—G alpha (i) signalling events—DRD2—nicotine dependence	5.03e-05	0.0122	CbGpPWpGaD
Levorphanol—OPRK1—GPCR ligand binding—OPRM1—nicotine dependence	4.98e-05	0.0121	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—FGD1—nicotine dependence	4.76e-05	0.0116	CbGpPWpGaD
Levorphanol—OPRK1—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	4.73e-05	0.0115	CbGpPWpGaD
Levorphanol—OPRM1—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	4.67e-05	0.0114	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—FGD1—nicotine dependence	4.43e-05	0.0108	CbGpPWpGaD
Levorphanol—OPRD1—GPCR ligand binding—DRD2—nicotine dependence	4.11e-05	0.01	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—TAS2R16—nicotine dependence	4.09e-05	0.00994	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—FGD1—nicotine dependence	4.02e-05	0.00979	CbGpPWpGaD
Levorphanol—OPRM1—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	4e-05	0.00973	CbGpPWpGaD
Levorphanol—OPRK1—GPCR ligand binding—DRD2—nicotine dependence	3.6e-05	0.00877	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—TAS2R16—nicotine dependence	3.58e-05	0.00872	CbGpPWpGaD
Levorphanol—OPRD1—GPCR downstream signaling—OPRM1—nicotine dependence	3.21e-05	0.00781	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—FGD1—nicotine dependence	3.21e-05	0.0078	CbGpPWpGaD
Levorphanol—OPRM1—GPCR ligand binding—DRD2—nicotine dependence	3.04e-05	0.00741	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—TAS2R16—nicotine dependence	3.03e-05	0.00737	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—OPRM1—nicotine dependence	2.92e-05	0.0071	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—AKR1B10—nicotine dependence	2.83e-05	0.00689	CbGpPWpGaD
Levorphanol—OPRK1—GPCR downstream signaling—OPRM1—nicotine dependence	2.82e-05	0.00685	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—FGD1—nicotine dependence	2.81e-05	0.00684	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—OPRM1—nicotine dependence	2.56e-05	0.00622	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—AKR1B10—nicotine dependence	2.48e-05	0.00604	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—FGD1—nicotine dependence	2.38e-05	0.00578	CbGpPWpGaD
Levorphanol—OPRD1—GPCR downstream signaling—DRD2—nicotine dependence	2.32e-05	0.00565	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—DRD2—nicotine dependence	2.11e-05	0.00513	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—AKR1B10—nicotine dependence	2.1e-05	0.00511	CbGpPWpGaD
Levorphanol—OPRK1—GPCR downstream signaling—DRD2—nicotine dependence	2.04e-05	0.00495	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—WASF2—nicotine dependence	2e-05	0.00486	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—WASF1—nicotine dependence	1.91e-05	0.00466	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—DRD2—nicotine dependence	1.85e-05	0.0045	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—WASF2—nicotine dependence	1.75e-05	0.00426	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—OPRM1—nicotine dependence	1.72e-05	0.00419	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—DRD2—nicotine dependence	1.72e-05	0.00419	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—WASF1—nicotine dependence	1.68e-05	0.00408	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—DRD2—nicotine dependence	1.56e-05	0.0038	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—OPRM1—nicotine dependence	1.51e-05	0.00368	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—WASF2—nicotine dependence	1.48e-05	0.0036	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—WASF1—nicotine dependence	1.42e-05	0.00345	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—DRD2—nicotine dependence	1.25e-05	0.00303	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—DRD2—nicotine dependence	1.09e-05	0.00266	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—DRD2—nicotine dependence	9.23e-06	0.00225	CbGpPWpGaD
